29 August 2018
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION: CLVLY) is pleased to announce that it will issue a dividend for the first time in its history for the 12-month financial reporting period ended 30 June 2018.
Subject to the Company maintaining sufficient reserves, the Board of Directors have agreed to issue an unfranked dividend of A$0.02 per ordinary share for the financial year ended 30 June 2018. The dividend record date is set at 24 September 2018. The payment date is set at 8 October 2018.